Agilon Health, Inc. — Form 8-K Summary
Business context and reporting period
Agilon Health furnished a Form 8-K on November 2, 2023, under Item 2.02 to announce financial results for the three and nine months ended September 30, 2023. The filing references a press release and supplemental financial information, but their contents are not included in the provided filing text.
Agilon completed the disposition of its MDX Hawaii operations on October 31, 2023. The supplemental information was intended to present selected unaudited non-GAAP financial information excluding MDX Hawaii for the periods shown.
Financial results and key metrics
- The filing states that results for the three and nine months ended September 30, 2023 were released, but it does not provide revenue, profit or loss, cash flow, margins, debt, liquidity, membership, medical-cost, or other financial figures.
- The filing text does not provide a clear value for any reported GAAP or non-GAAP metric.
- Information excluding MDX Hawaii is described as unaudited and non-GAAP; the underlying amounts and reconciliations are not included in the supplied text.
Material changes versus the prior comparable period
The filing identifies the disposition of MDX Hawaii as a material reporting change and indicates that supplemental information excluding the disposed operations was provided to assist comparisons. The filing text does not quantify the effect of the disposition or provide comparable-period changes.
Guidance, outlook, risks, and unusual items
- No guidance or outlook figures are included in the filing text.
- The MDX Hawaii disposition is the principal unusual item identified.
- The filing does not describe specific risks, contingencies, or management commentary beyond the issuance of the results and supplemental information.
- Item 2.02 information and Exhibits 99.1 and 99.2 were furnished rather than filed for purposes of Section 18 of the Exchange Act, except where expressly incorporated by reference.
Investor verification checklist
- Review Exhibit 99.1 for reported GAAP results, operating metrics, cash flow, liquidity, and management commentary.
- Review Exhibit 99.2 for the non-GAAP presentation excluding MDX Hawaii and the related reconciliations.
- Verify the accounting and financial impact of the October 31, 2023 MDX Hawaii disposition.
- Confirm any updated guidance, membership expectations, medical-cost trends, and liquidity or capital requirements in the exhibits.